H.LUNDBECK 20/27 MTNH.LUNDBECK 20/27 MTNH.LUNDBECK 20/27 MTN

H.LUNDBECK 20/27 MTN

No trades
See on Supercharts
Overview
Analysis

Key terms


Outstanding amount
‪500.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
0.88% (Fixed)
Coupon frequency
Annual
Yield to maturity
3.03%
Maturity date
Oct 14, 2027
Term to maturity
2 years

About H.LUNDBECK 20/27 MTN


Sector
Health Technology
Home page
Issue date
Oct 14, 2020
ISIN
XS2243299463
H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Markets. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.